Aetna, a CVS Health company (NYSE:CVS), announced on Tuesday that it is introducing a generative AI-powered conversational experience in its digital channels designed to simplify healthcare.
This offering will allow members to quickly and easily navigate their benefits for a personalised experience.
The new capability was initially launched to a limited population in October, with access expanding throughout the rest of 2025 and the first half of 2026.
Aetna members will be able to use their device to verbally interact with the assistant with full voice enablement. The assistant will also be embedded within Aetna's recently announced Care Paths feature, a digital experience to help members navigate certain conditions.
Neola Medical secures US patent for disposable lung monitoring probes
Remington Medical's VascuChek 2.0 Cordless Bluetooth-Enabled Doppler Secures FDA Clearance
Aetna to launch generative AI-powered conversational experience
Maxx Orthopedics Receives FDA 510(k) Clearance for Its Libertas® Bipolar Hip System
Ascletis Pharma announces ASC36 and ASC35 co-formulation for clinical development
Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies
Nurami Medical completes Phase 1 milestones in EIC-backed grant for Artifix
Organon to sell JADA System to Laborie for up to USD465m
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
BD launches IVDR-certified self-collection solution to expand global access to HPV testing
Oticon launches Oticon Zeal, a discreet, fully featured in-the-ear hearing aid
Halozyme Therapeutics announces Q3 2025 release date
Samsung to invest USD110m in GRAIL and commercialise cancer detection test Galleri in Asia